Creative Medical Technology Holdings, Inc. (CELZ) は上場企業です ヘルスケア セクターの バイオテクノロジー 業界で事業展開. 本社所在地は Phoenix, AZ, アメリカ. 現CEOは Timothy Warbington.
CELZ を有する IPO日 2015-11-06, 4 名の正社員, に上場 NASDAQ Capital Marke, 時価総額 $5.91M.
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.
